Targocid is a glycopeptide antibiotic. It is a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core, termed teicoplanin A3-1, a fused ring structure to which two carbohydrates (mannose and N-acetylglucosamine) are attached. The major and minor components also contain a third carbohydrate moiety, β-D-glucosamine, and differ only by the length and conformation of a side chain attached to it. .

Targocid - Pharmacology:

Targocid inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death.

Generic name, Overdose, Half Life Targocid, Food Interactions, Chemical, etc..

Targocid see also

Brand Names containing Teicoplanin